Tralokinumab therapy for moderate-to-severe atopic dermatitis: Clinical outcomes with targeted IL-13 inhibition

Simpson, EL; Guttman-Yassky, E; Eichenfield, LF; Boguniewicz, M; Bieber, T; Schneider, S; Guana, A; Silverberg, JI

Simpson, EL (通讯作者)，Oregon Hlth & Sci Univ, Dept Dermatol, 3303 Southwest Bond Ave, Portland, OR 97239 USA.

ALLERGY, 2023; 78 (11): 2875

Abstract

Atopic dermatitis (AD) is a chronic, inflammatory, intensely pruritic skin disorder associated with significant patient burden. Interleukin (IL)-13 is......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索